Advanced Hematologic Malignancies

Explore clinical trials studying Advanced Hematologic Malignancies. Study availability and eligibility vary by location and protocol.

6 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Advanced Hematologic Malignancies trial results

Recruiting

NCT07444268

Conditions: Advanced Hematologic Malignancies
Locations: University of North Carolina Chapel Hill, North Carolina, United States

MD Anderson Cancer Center Houston, Texas, United States

Recruiting

NCT07113925

Conditions: Advanced Hematologic Malignancies
Locations: The Henan Cancer Hospital Zhengzhou, Henan, China

The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China

Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

Completed

NCT01034475

Conditions: Advanced Hematologic Malignancies, Blood Protein Disorders, Cardiovascular Diseases, +19 more
Locations: Wake Forest University Health Sciences Winston-Salem, North Carolina, United States

Completed

NCT01344707

Conditions: Advanced Hematologic Malignancies, Blood Protein Disorders, Bone Marrow Diseases, +30 more
Locations: Universiätsklinikum Köln Cologne, Germany

Robert-Bosch-Krankenhaus Stuttgart, Germany

Universitätsklinikum Würzburg Würzburg, Germany

Completed

NCT00943592

Conditions: Advanced Hematologic Malignancies, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: The University of Chicago Chicago, Illinois, United States

Active, Not Recruiting

NCT05088356

Conditions: Acute Leukemia, Advanced Hematologic Malignancies, Allogeneic Hematopoietic Cell Transplantation (HCT), +15 more
Locations: Stanford University Stanford, California, United States